Objective: To report our experience in patients with critical limb ischemia (CLI) due to isolated below-the-knee (BTK) arterial lesions. Methods: Between 1992 and 2009, we performed 2747 peripheral angioplasties, while 2.8% (78 of 2747) were only BTK and were included in the present study. Results: Mean age was 70.2 ± 11 years, 58.4% had diabetic, 85.7% were smokers, and 20.8% had chronic renal failure. Baseline Rutherford class: 50 patients with class IV and 27 with class V to VI. Angiographic and clinical success were 97.4% and 90.91%, respectively. At 30 days, there were no deaths, 2 patients had acute vessel closure and 2 major amputation. At long-term follow-up (22.4 ± 9.6 months), there were 7 unrelated deaths (10%), 5 amputations (7.1%), 3 reinterventions (4.2%), while 16 patients remained symptomatic. Overall amputation and amputation plus claudication-free survival were 90% and 70%, respectively. Conclusion: Endovascular treatment of BTK lesions represents a safe and effective treatment option to patients with CLI.
Heidrich H., Allenberg J., Cachovan M., et al. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology. Vasa. 1992;21(4):333-343.
2.
Nair V., Chaisson G., Abben R.Strategies in infrapopliteal intervention: improving outcomes in challenging patients. J Interv Cardiol.2009;22(1):27-36.
3.
Dormandy JA, Rutherford RBManagement of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1pt2):S1-S296.
4.
Kalra M., Gloviczki P., Bower TC, et al. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg. 2001;33(1):6-16.
5.
Mohler E. III , Giri J.Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines. Curr Med Res Opin. 2008;24(9):2509-2522.
6.
Norgren L., Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1-S75.
7.
Criqui MH, Langer RD, Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381-386.
8.
Yokoi Y.Infrapopliteal artery angioplasty: PCI like, but not a coronary artery. Catheter Cardiovasc Interv. 2008;72(5):714-715.
9.
Dorros G., Jaff MR, Dorros AM, Mathiak LM, He T.Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation. 2001;104(17):2057-2062.
10.
Varty K., Bolia A., Naylor AR, Bell PR, London NJInfrapopliteal percutaneous transluminal angioplasty: a safe and successful procedure. Eur J Vasc Endovasc Surg. 1995;9(3):341-345.
11.
Laird JR, Zeller T., Gray BH, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13(1):1-11.
12.
Saab MH, Smith DC, Aka PK, Brownlee RW, Killeen JDPercutaneous transluminal angioplasty of tibial arteries for limb salvage . Cardiovasc Intervent Radiol. 1992;15(4):211-216.
13.
Bergan JJ, Veith FJ, Bernhard VM, et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery. 1982;92(6):921-930.
14.
Bergan JJ, Yao JS, Flinn WR, Graham LMProsthetic grafts for the treatment of lower limb ischaemia: present status . Br J Surg.1982;69(suppl):S34-S37.
15.
Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DSInfrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg. 1991;13(5):631-636.
16.
Hobson RW II , Lynch TG , Jamil Z., et al. Results of revascularization and amputation in severe lower extremity ischemia: a five-year clinical experience. J Vasc Surg. 1985;2(1):174-185.
17.
Fusaro M., Agostoni P., Biondi-Zoccai G.‘‘Trans-collateral’’ angioplasty for a challenging chronic total occlusion of the tibial vessels: a novel approach to percutaneous revascularization in critical lower limb ischemia. Catheter Cardiovasc Interv. 2008; 71(2):268-272.
18.
Laird JR, Dawson DLThe role for cryoplasty in the treatment of infrainguinal artery disease: case studies. J Endovasc Ther.2009; 16(2suppl2):11116-11128.
19.
Feiring AJ, Krahn M., Nelson L., Wesolowski A., Eastwood D., Szabo A.Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial . J Am Coll Cardiol.2010;55(15):1580-1589.
20.
Siablis D., Katsanos K., Karnabatidis D.Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe. J Endovasc Ther. 2010;17(4):488-491.
21.
Bosiers M., Deloose K., Keirs K., Verbist J., Peeters P.Prevention and treatment of in-stent restenosis. J Cardiovasc Surg (Torino). 2010;51(4):591-598.
22.
Balzer JO, Zeller T., Rastan A., et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino). 2010;51(2): 183-191.
23.
Spiliopoulos S., Katsanos K., Karnabatidis D., et al. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol.2010;33(5):929-938.
24.
Bosiers M., Deloose K., Vermassen F., et al. The use of the cryoplasty technique in the treatment of infrapopliteal lesions for Critical Limb Ischemia patients in a routine hospital setting: one-year outcome of the Cryoplasty CLIMB Registry. J Cardiovasc Surg (Torino). 2010;51(2):193-202.
25.
Ferraresi R. , Centola M., Ferlini M., et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg.2009;37(3):336-342.
